The Role of Cytokines in the Modulation of Cell Surface Antigens of Human Melanoma

A number of different cytokines, including IL-1α. and ß, IL-2, IL-3, IL-4, IL-6, IL-7, IL-8, IFN-α, -ß and γ, TNF-α -ß, and TGF-ß1, can modulate the expression of distinct cell surface antigens of normal and neoplastic cells. Both induction/increase of expression and reduction of expression can be achieved depending on the antigen and on the cytokine. Antigens subjected to the modulating activity of cytokines include distinct families of cell surface structures such as the molecules coded by the major histocompatibility complex (MHC), the superfamily of adhesion receptors that regulate cell-cell and cell-matrix interaction, receptors for cytokines and growth factors and tumor-associated antigens. The modulating activity of cytokines is a consequence of their influence on gene expression, protein synthesis, membrane expression and shedding of antigens from the cell surface. The changes of phenotype due to the action of cytokines can influence the signalling pathways dependent on the expression and function of cell surf ace structures. Therefore, the antigen modulating activity of cytokines can thoroughly affect the biological behavior of normal and neoplastic cells. As described here, most of the modulating effects of cytokines on different cell surface structures and the functional consequences of antigenic modulation can be verified in human malignant melanoma cells.

[1]  S. Bernasconi,et al.  Regulated expression of vascular cell adhesion molecule-1 in human malignant melanoma. , 1992, The American journal of pathology.

[2]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[3]  T. Luger,et al.  Modulation of intercellular adhesion molecule-1 expression on human melanocytes and melanoma cells: evidence for a regulatory role of IL-6, IL-7, TNF beta, and UVB light. , 1992, The Journal of investigative dermatology.

[4]  A. Mantovani,et al.  Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. , 1991, Cancer research.

[5]  A. Anichini,et al.  Heterogeneity for integrin expression and cytokine‐mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins , 1991, International journal of cancer.

[6]  A. Anichini,et al.  Cytokine‐mediated modulation of HLA‐class II, ICAM‐1, LFA‐3 and tumor‐associated antigen profile of melanoma cells. comparison with anti‐proliferative activity by RIL1‐β, RTNF‐α, RIFN‐γ, RIl4 and their combinations , 1990 .

[7]  G. Sozzi,et al.  Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma. , 1987, Journal of immunology.

[8]  A. Anichini,et al.  Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon γ , 1986, International journal of cancer.

[9]  S. Pestka,et al.  Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons. , 1986, Anticancer research.

[10]  S. Ferrone,et al.  Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon. , 1985, Cancer research.